Acute myeloid leukemia in HIV-positive patients: biological crossroads and therapeutic Hurdles
Mohamed J Saadh, Faris Anad Muhammad, Rafid Jihad Albadr, Vimal Arora, Subbulakshmi Ganesan, Aman Shankhyan, Ajay Sharma, Jasur Rizaev, Waam Mohammed Taher, Mariem Alwan, Mahmood Jasem Jawad, Ali M Ali Al-Nuaimi · 2026
Read Acute myeloid leukemia in HIV-positive patients: biological crossroads and therapeutic Hurdles by Mohamed J Saadh, Faris Anad Muhammad, Rafid Jihad Albadr, Vimal Arora, Subbulakshmi Ganesan, Aman Shankhyan, Ajay Sharma, Jasur Rizaev, Waam Mohammed Taher, Mariem Alwan, Mahmood Jasem Jawad, Ali M Ali Al-Nuaimi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13395962.txt.
Description
Mohamed J Saadh and others review acute myeloid blood cancer in HIV-positive people in a 2026 paper. Blood cancer in this group may speed up through long defense flare, oxygen stress, and marrow upset, while blood cancer-linked defense loss can worsen HIV illness.
Shared signs like low blood counts and repeat germ attacks oft blur diagnosis, and strong chemo stays the norm despite drug clashes and piled-up harms with HIV drugs. The review maps where the two illnesses cross and where care trips up. Doctors gain a guide for steering two fierce illnesses at once without letting one cure wreck the other.
Catalog record
| CREATOR | Mohamed J Saadh, Faris Anad Muhammad, Rafid Jihad Albadr, Vimal Arora, Subbulakshmi Ganesan, Aman Shankhyan, Ajay Sharma, Jasur Rizaev, Waam Mohammed Taher, Mariem Alwan, Mahmood Jasem Jawad, Ali M Ali Al-Nuaimi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |